Form D · Pharmaceuticals
ZoMedica Pharmaceuticals Inc.
Ann Arbor, MI · CIK 0001662582
Offering snapshot reported Jan 5, 2016 · SEC filing
- Reported sold
- $2.88M Offering amount: $2.88M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 5, 2016 | Initial | $2,884,889 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-254450
U.S. dollar amounts are based on the Bank of Canada noon rate of exchange reported on December 22, 2015, which was Cdn$1.3929=US$1.00.
Source: Form D, filed Jan 5, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jim Lebar | Director |
| William Mac Arthur | Director, Executive |
| Stephanie Morley | Executive |
| Jerry Solensky | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3928 Varsity Drive
Ann Arbor, MI, 48108
Ann Arbor, MI, 48108